News & Updates

Show Multimedia Only

Histologic margin status predicts relapse in lentigo maligna melanoma

26 Oct 2023

Histologic margin status shows a robust association with progression for lentigo maligna melanoma, suggest the results of a recent study.

26 Oct 2023

Brentuximab vedotin fares well for CTCL in real-world study

26 Oct 2023 by

Interim findings from a prospective real-world study in Poland demonstrated favourable clinical outcomes and a tolerable safety profile for the CD30-directed antibody-drug conjugate brentuximab vedotin in patients with CD30-expressing cutaneous T-cell lymphoma (CTCL).

26 Oct 2023

Niraparib tied to more toxicities than olaparib in ovarian cancer

25 Oct 2023

Use of niraparib appears to contribute to a higher risk of haematological toxicities as compared with olaparib, suggests a study. The most common haematological adverse event is anaemia.

25 Oct 2023

$Anlotinib shows promise for radioiodine-refractory differentiated thyroid carcinoma$

Anlotinib shows promise for radioiodine-refractory differentiated thyroid carcinoma

20 Oct 2023

The multikinase inhibitor anlotinib appears to have promising antitumour activity in the treatment of locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma while having an acceptable safety profile, as shown in a phase II study.

20 Oct 2023

First-line therapies for advanced NSCLC improve survival, QoL

16 Oct 2023

Clinical trials on first-line therapies for advanced or metastatic nonsmall cell lung cancer (NSCLC) from 2010 to 2020 have reported better survival and a steady improvement in quality of life (QoL) among patients, according to the results of a systematic review.

16 Oct 2023

Behavioural interventions improve screening colonoscopy uptake

16 Oct 2023 by

Use of behavioural interventions, specifically multicomponent and patient navigation interventions, helps increase the uptake of colonoscopy for colorectal cancer (CRC) screening, reveals a study.

16 Oct 2023

Physical activity boosts functional performance in MM

16 Oct 2023 by

Exercises that include walking and resistance training are effective interventions that improve frailty in patients with multiple myeloma (MM) who are receiving systemic treatment, according to a new study.

16 Oct 2023

Lung cancer screening feasible for Asian women who don’t smoke

13 Oct 2023 by

Lung cancer screening with low-dose computed tomography (LDCT) may be offered to nonsmoking Asian women, with data from the Female Asian Nonsmoker Screening Study (FANSS) showing that screening yields an invasive lung adenocarcinoma detection rate of 1.5 percent.

13 Oct 2023

Free PSA improves prediction of prostate cancer

13 Oct 2023

Adding percent free prostate-specific antigen (PSA) to total PSA results in better prediction of clinically significant prostate cancer and fatal prostate cancer in men, reports a study.

13 Oct 2023

Osimertinib plus chemo bumps up PFS in advanced EGFR-mutated NSCLC

12 Oct 2023 by

In the first-line treatment of patients with advanced nonsmall cell lung cancer (NSCLC) harbouring EGFR mutation, the combination of osimertinib plus pemetrexed and platinum-based chemotherapy outperformed osimertinib alone in terms of extending progression-free survival (PFS), according to the interim results of the phase III FLAURA2 trial presented at WCLC 2023.

12 Oct 2023

News & Updates

Showing Oncology articles

Showing

Specialty:

Histologic margin status predicts relapse in lentigo maligna melanoma

Brentuximab vedotin fares well for CTCL in real-world study

Niraparib tied to more toxicities than olaparib in ovarian cancer

Anlotinib shows promise for radioiodine-refractory differentiated thyroid carcinoma

First-line therapies for advanced NSCLC improve survival, QoL

Behavioural interventions improve screening colonoscopy uptake

Physical activity boosts functional performance in MM

Lung cancer screening feasible for Asian women who don’t smoke

Free PSA improves prediction of prostate cancer

Osimertinib plus chemo bumps up PFS in advanced EGFR-mutated NSCLC